Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00129792 · ClinicalTrials.gov registry record · NA

Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
79
Enrollment target

NCT00129792 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 79 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00129792, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target

Study Summary

This study will determine the effects of a supplement in reducing symptoms of metabolic syndrome, a collection of symptoms that increase the risk for developing heart disease, stroke, and diabetes.

Interventions

  • DRUG Dietary supplement for weight loss
  • BEHAVIORAL Education and counseling for weight loss

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2005-01
Est. Completion 2014-04
Phase NA

What the Registry Record Tells You About NCT00129792

The ClinicalTrials.gov registry entry for NCT00129792 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Dietary supplement for weight loss is the first listed.

NCT00129792 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00129792 about?

NCT00129792 is a clinical study titled "Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome". This study will determine the effects of a supplement in reducing symptoms of metabolic syndrome, a collection of symptoms that increase the risk for developing heart disease, stroke, and diabetes.

What is the current status of trial NCT00129792?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2005-01. Estimated completion is 2014-04.

What interventions are being tested in trial NCT00129792?

The interventions under investigation include: Dietary supplement for weight loss (DRUG), Education and counseling for weight loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT00129792?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.